Luxfer Holdings Plc
LXFR NYSE Industrial Inorganic Chemicals Financials FY2016βFY2025
What Luxfer Holdings Plc does
No business description yet.
- Legal name
- LUXFER HOLDINGS PLC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001096056-26-000015
0001096056
Revenue and margins
Luxfer Holdings Plc had $385M of revenue in fiscal 2025, down 1.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β9.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $26.2M in fiscal 2025, 6.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Luxfer Holdings Plc returned $17.0M to shareholders in fiscal 2025, 65% of free cash flow. The diluted share count rose 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Luxfer Holdings Plc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.2M | $12.6M | $2.3M | $4.1M | $8.3M |
| Debt incl. finance leases | $59.6M | $106M | $76.8M | $48.2M | $64.4M |
| Net debt / EBITDA | 1.0x | 1.6x | 4.4x | 1.1x | 1.7x |
| Debt / equity | 0.3x | 0.5x | 0.4x | 0.2x | 0.3x |
| Interest coverage | 11.7x | 11.5x | 0.7x | 5.8x | 7.7x |
| Current ratio | 1.9x | 1.8x | 2.6x | 1.9x | 1.7x |
| Quick ratio | 0.9x | 0.8x | 1.1x | 1.0x | 0.7x |
| Total assets | $369M | $407M | $372M | $382M | $370M |
| Total liabilities | $160M | $200M | $160M | $163M | $143M |
| Shareholders' equity | $209M | $207M | $213M | $220M | $226M |
| Net debt (β = net cash) | $53.4M | $93.6M | $74.5M | $44.1M | $56.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 7 | 6 / 9 | 4 / 9 | 5 / 9 | 5 / 9 | 4 / 9 | 6 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | β0.7% | β5.4% | β9.3% | β0.7% | β8.0% | 1.1% | 2.8% | β7.2% | β8.7% | β7.0% |
| Altman Z'' | β | 3.14 | 3.62 | 3.75 | 4.01 | 4.40 | 4.26 | 4.22 | 4.28 | 4.17 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $415M | $441M | $402M | $373M | $325M | $374M | $423M | $405M | $392M | $385M |
| Net interest income | β$6.0M | β$6.3M | β$4.5M | β$4.4M | β$5.0M | β$3.1M | β$3.9M | β$6.3M | β | β |
| Gross profit | $94.6M | $109M | $118M | $104M | $80.9M | $96.0M | $95.0M | $76.6M | $85.7M | $89.2M |
| Research and development | $7.6M | $7.8M | $6.3M | $5.7M | $3.3M | $3.9M | $4.9M | $4.6M | $4.4M | $4.3M |
| Operating income | $32.9M | $21.9M | $33.6M | $18.7M | $28.5M | $36.2M | $44.8M | $4.2M | $30.1M | $24.0M |
| Interest expense | $6.3M | $6.6M | $4.9M | $4.5M | $5.0M | $3.1M | $3.9M | $6.3M | $5.2M | $3.1M |
| Pretax income | $24.1M | $19.8M | $33.8M | $15.6M | $27.8M | $35.4M | $41.0M | β$9.7M | $26.5M | $22.2M |
| Income tax | $6.8M | $3.3M | $6.5M | $7.6M | $6.9M | $5.4M | $9.0M | β$7.1M | $8.2M | $9.1M |
| Net income | $17.8M | $16.6M | $25.0M | $3.1M | $20.0M | $29.9M | $26.9M | β$1.9M | $18.4M | $7.7M |
| Diluted EPS | $0.67 | $0.62 | $0.90 | $0.11 | $0.72 | $1.07 | $0.98 | β$0.07 | $0.68 | $0.28 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $20.6M | $38.8M | $63.2M | $5.8M | $49.6M | $26.1M | $15.9M | $26.3M | $51.1M | $34.0M |
| Capital expenditure | $16.6M | $10.5M | $13.2M | $13.1M | $8.0M | $9.1M | $8.3M | $9.4M | $10.3M | $7.8M |
| Free cash flow | $4.0M | $28.3M | $50.0M | β$7.3M | $41.6M | $17.0M | $7.6M | $16.9M | $40.8M | $26.2M |
| Depreciation and amortization | $18.0M | $18.3M | $16.9M | $13.2M | $13.3M | $15.6M | $13.6M | $12.7M | $10.1M | $9.9M |
| Stock-based compensation | $1.4M | $3.1M | $4.8M | $4.5M | $2.8M | $2.8M | $2.5M | $2.8M | $3.5M | $3.6M |
| Acquisitions | $0.3M | $4.7M | β$2.7M | $0.0M | $0.0M | $19.3M | $0.0M | $0.0M | β | β |
| Share buybacks | $7.3M | $0.0M | $0.0M | $0.0M | $0.0M | $6.4M | $11.1M | $2.7M | $2.3M | $3.1M |
| Dividends paid | $13.3M | $13.3M | $13.4M | $13.6M | $13.6M | $13.6M | $14.2M | $14.0M | $14.0M | $13.9M |
| Dividends and buybacks | $20.6M | $13.3M | $13.4M | $13.6M | $13.6M | $20.0M | $25.3M | $16.7M | $16.3M | $17.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $13.6M | $12.6M | $13.8M | $10.2M | $1.5M | $6.2M | $12.6M | $2.3M | $4.1M | $8.3M |
| Total debt | β | $133M | $80.6M | $91.4M | $53.4M | $59.6M | $106M | $76.8M | $48.2M | $64.4M |
| Current assets | β | $171M | $181M | $189M | $151M | $163M | $201M | $169M | $176M | $164M |
| Current liabilities | β | $84.0M | $91.2M | $77.5M | $65.4M | $83.9M | $110M | $64.8M | $93.7M | $98.2M |
| Inventory | β | $82.2M | $93.6M | $77.6M | $68.8M | $90.5M | $111M | $95.9M | $83.6M | $92.4M |
| Property and equipment, net | $129M | $129M | $107M | $90.2M | $86.0M | $87.5M | $77.7M | $63.8M | $62.8M | $60.2M |
| Goodwill | $67.9M | $71.2M | $67.6M | $68.8M | $70.2M | $69.7M | $65.6M | $67.5M | $67.0M | $69.6M |
| Intangible assets | β | $16.1M | $14.6M | $13.6M | $12.8M | $13.7M | $12.5M | $12.0M | $11.5M | $10.9M |
| Total assets | $400M | $416M | $409M | $390M | $346M | $369M | $407M | $372M | $382M | $370M |
| Total liabilities | β | $241M | $225M | $216M | $179M | $160M | $200M | $160M | $163M | $143M |
| Shareholders' equity | $150M | $175M | $184M | $174M | $167M | $209M | $207M | $213M | $220M | $226M |
| Margins | ||||||||||
| Gross margin | 22.8% | 24.6% | 29.3% | 27.8% | 24.9% | 25.7% | 22.4% | 18.9% | 21.9% | 23.2% |
| Operating margin | 7.9% | 5.0% | 8.4% | 5.0% | 8.8% | 9.7% | 10.6% | 1.0% | 7.7% | 6.2% |
| EBITDA margin | 12.3% | 9.1% | 12.6% | 8.5% | 12.9% | 13.8% | 13.8% | 4.2% | 10.3% | 8.8% |
| Net margin | 4.3% | 3.8% | 6.2% | 0.8% | 6.2% | 8.0% | 6.4% | β0.5% | 4.7% | 2.0% |
| FCF margin | 1.0% | 6.4% | 12.4% | β2.0% | 12.8% | 4.5% | 1.8% | 4.2% | 10.4% | 6.8% |
| Net interest share of revenue | β1.4% | β1.4% | β1.1% | β1.2% | β1.5% | β0.8% | β0.9% | β1.6% | β | β |
| Returns | ||||||||||
| Return on capital | β | 6.2% | 10.8% | 4.8% | 9.8% | 11.7% | 11.6% | 1.2% | 7.9% | 5.5% |
| Return on capital employed | β | 6.6% | 10.6% | 6.0% | 10.1% | 12.7% | 15.1% | 1.4% | 10.4% | 8.8% |
| Return on equity | 11.8% | 10.2% | 13.9% | 1.7% | 11.7% | 15.9% | 12.9% | β0.9% | 8.5% | 3.5% |
| Return on assets | 4.5% | 4.1% | 6.1% | 0.8% | 5.4% | 8.4% | 6.9% | β0.5% | 4.9% | 2.0% |
| Return on tangible equity | 21.6% | 19.0% | 24.5% | 3.4% | 23.8% | 23.8% | 20.8% | β1.4% | 13.0% | 5.3% |
| Growth | ||||||||||
| Revenue growth | β | 6.4% | β8.9% | β7.1% | β13.0% | 15.2% | 13.2% | β4.3% | β3.2% | β1.9% |
| Net income growth | β | β6.7% | 50.6% | β87.6% | 545.2% | 49.5% | β10.0% | β107.1% | β | β58.2% |
| EPS growth | β | β7.5% | 45.2% | β87.8% | 554.5% | 48.6% | β8.4% | β107.1% | β | β58.8% |
| FCF growth | β | 607.5% | 76.7% | β114.6% | β | β59.1% | β55.3% | 122.4% | 141.4% | β35.8% |
| Share count change | β | 0.3% | 3.6% | 0.7% | 0.3% | 0.2% | β1.8% | β1.9% | 0.2% | 0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 3.0x | 1.3x | 2.5x | 1.2x | 1.0x | 1.6x | 4.4x | 1.1x | 1.7x |
| Debt / equity | β | 0.8x | 0.4x | 0.5x | 0.3x | 0.3x | 0.5x | 0.4x | 0.2x | 0.3x |
| Interest coverage | 5.2x | 3.3x | 6.9x | 4.2x | 5.7x | 11.7x | 11.5x | 0.7x | 5.8x | 7.7x |
| Current ratio | β | 2.0x | 2.0x | 2.4x | 2.3x | 1.9x | 1.8x | 2.6x | 1.9x | 1.7x |
| Quick ratio | β | 1.1x | 1.0x | 1.4x | 1.3x | 0.9x | 0.8x | 1.1x | 1.0x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.0% | 2.4% | 3.3% | 3.5% | 2.5% | 2.4% | 2.0% | 2.3% | 2.6% | 2.0% |
| Stock comp / revenue | 0.3% | 0.7% | 1.2% | 1.2% | 0.9% | 0.7% | 0.6% | 0.7% | 0.9% | 0.9% |
| Payouts / FCF | 515.0% | 47.0% | 26.8% | β | 32.7% | 117.6% | 332.9% | 98.8% | 40.0% | 64.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 4.0 | 5.0 | 5.0 | 4.0 | 6.0 | 6.0 | 5.0 |
| Altman Z'' | β | 3.1 | 3.6 | 3.7 | 4.0 | 4.4 | 4.3 | 4.2 | 4.3 | 4.2 |
| Accruals ratio | β0.7% | β5.4% | β9.3% | β0.7% | β8.0% | 1.1% | 2.8% | β7.2% | β8.7% | β7.0% |
Source: SEC EDGAR XBRL filings (CIK 0001096056). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.